Yahoo Finance

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today announced the results of ...
Becker's Hospital Review

Advancing Real World Wound Care with Dr. Jaideep Banerjee of Smith+Nephew

This episode features Dr. Jaideep Banerjee, Director of Global Clinical & Medical Affairs at Smith+Nephew, discussing the challenges of chronic wound care, the importance of standardized ...
Nasdaq

MediWound Ltd. Publishes Post Hoc Analysis Comparing EscharEx® and Collagenase Ointment in Wounds Journal

MediWound Ltd. announced the publication of a peer-reviewed post hoc analysis in the journal Wounds, based on data from its Phase II ChronEx clinical trial for patients with venous leg ulcers (VLUs).
Houston Chronicle

(PRN) HEALTHPOINT to Begin Marketing and Selling Collagenase SANTYL (R)

FORT WORTH, Texas, April 4 /PRNewswire/-- HEALTHPOINT, Ltd., a DFB Pharmaceuticals Inc. affiliate company, today announced that it will begin marketing and selling the Collagenase SANTYL(R) Ointment ...
Seeking Alpha

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

YAVNE, Israel, April 25, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, announced today that recent clinical data from ...
Yahoo Finance

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

YAVNE, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the publication of a ...
Mena FN

Santyl Global Market Report 2025: Significant Growth Expected Amid Rising Chronic Wound Cases

Santyl Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Santyl Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 ...
Stockhouse

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Results demonstrate superiority of EscharEx®, a bromelain-based gel vs. SANTYL®, a collagenase ointment, in wound debridement, promotion of granulation tissue, and time to wound ...